The Zhitong Finance App learned that the Hong Kong Stock Prospectus submitted by Shanghai Orkeda Pharmaceutical Technology Co., Ltd. (abbreviation: Okeda Pharmaceutical) on January 26, 2026 expired on July 26, 2026. China Merchants Securities International and CCB International were co-sponsors.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.